Skip to main content
S&P 5007,580.07-1.82%DOW51,770.31-1.09%NASDAQ25,437.00-2.86%BTC$77,415.00+0.36%ETH$2,246.32+1.22%GOLD$3,884.90-3.63%OIL$102.95+0.93%
Smart Investors Daily
SID Premium
EN

NASDAQ · ENSG

The Ensign Group, Inc.

Healthcare · Medical - Care Facilities

$181.52

Down-$4.80 (-2.58%)

Updated Nov 1, 2026, 7:51 PM

SID Score

6.3/10

Composite research score

Smart Money

58/100

Neutral

Market cap
10.02B
P/E ratio
30.45
Dividend yield
0.14%
52-week range
$141.58 – $218.00
Volume
411.63K
Avg. volume
398.39K

Price performance · ENSG

ENSG price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 30, 2026

ENSG closed at $181.52 after 20 trading sessions, up 4.99% for the selected period.

Last close
$181.52
Period change
+4.99%
Period low
$169.22
Period high
$186.32
Daily close
View OHLC price history
ENSG OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 30, 2026$186.73$187.99$181.02$181.52411.63K
Oct 29, 2026$187.99$189.00$183.9125$186.32465.45K
Oct 28, 2026$178.23$187.25$175.34$184.11974.05K
Oct 27, 2026$175.20$176.99$168.43$169.50674.16K
Oct 26, 2026$177.25$180.75$175.8013$176.92490.01K
Oct 23, 2026$177.54$178.27$175.59$175.59248.73K
Oct 22, 2026$173.62$178.63$172.12$178.35307.8K
Oct 21, 2026$175.23$176.74$173.20$173.35286.58K
Oct 20, 2026$173.80$176.21$173.25$176.00328.97K
Oct 19, 2026$174.68$177.195$172.23$173.05277.41K
Oct 16, 2026$179.62$179.94$176.02$176.63288.15K
Oct 15, 2026$178.94$180.02$177.44$178.11343.8K
Oct 14, 2026$172.60$175.89$172.60$175.85292.37K
Oct 13, 2026$175.28$175.29$172.575$173.26275.16K
Oct 12, 2026$172.92$175.3894$172.92$173.92231.81K
Oct 9, 2026$171.36$173.7599$171.36$171.80205.33K
Oct 8, 2026$168.64$171.64$168.64$171.49354.94K
Oct 7, 2026$172.89$172.89$168.84$169.22458.21K
Oct 6, 2026$173.72$174.98$170.71$172.06416.87K
Oct 5, 2026$171.78$174.43$171.19$172.89476.54K

Latest ENSG news

The latest Smart Investors Daily articles mentioning ENSG.

Stock researchCompany · Overview

ENSG research

Overview

Company profile and research snapshot.

Company profile

Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$208.67
Implied upside
—
Analysts
11
ENSG recent ratings
DateFirmRatingTarget
Oct 29, 2026OppenheimerOutperform—
Oct 29, 2026Truist SecuritiesHold—
Oct 29, 2026UBSBuy—
Jul 30, 2026Truist SecuritiesHold—
Jul 14, 2026Truist SecuritiesHold—
Open full forecast

News briefing

Generated Nov 1, 2026, 5:16 PM

Why Is ENSG Down Today?

The Ensign Group shares declined 2.58% today despite positive Q3 earnings results highlighting organic growth and acquisition-driven occupancy gains. The market's muted reaction suggests investors may be pricing in fair valuation on current cash flow metrics, with gains already reflected in recent performance.

    Bottom line: ENSG's Q3 results are solid, but the stock's decline reflects a market assessment that current valuations fairly reflect the company's cash flow generation and growth prospects. Investors should monitor whether the company can sustain margin expansion and deliver acquisitions at attractive returns, as these will be critical to justifying further upside.

    Yahoo · Oct 31, 2026

    ENSG Q3 deep dive: organic growth and acquisitions drive occupancy and margin gains

    Healthcare services company The Ensign Group (NASDAQ:ENSG) fell short of the market’s revenue expectations in Q3 2026, but sales rose 14.5% year on year to $1.48 billion. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $5.91 billion at the midpoint. Its GAAP profit of $1.76 per share was 2.8% below analysts’ consensus estimates.

    Yahoo · Oct 30, 2026

    Ensign Group (ENSG) Stock May Be Near Fair Value On Cash Flow

    Ensign Group has delivered a strong run over the past few years, and the share price now reflects a lot of optimism. The live question is whether that price is in line with the cash flows the business is expected to generate. Over the last 5 years the stock has returned 143.3%, which puts real weight on whether those gains are backed by the underlying cash flow stream. The group runs a cash generative post-acute care model, so the value investors place on the shares may hinge on how...

    Yahoo · Oct 30, 2026

    The 5 most interesting analyst questions from The Ensign Group’s Q3 earnings call

    The Ensign Group’s third quarter drew a positive market reaction despite missing Wall Street’s revenue and earnings per share expectations, as investors looked beyond headline numbers to underlying business momentum. Management attributed the quarter’s performance to continued gains in occupancy and skilled mix, with CEO Barry Port highlighting a “relentless patient-focused culture” and ongoing success in integrating new operations. The company’s clinical outcomes, validated by above-average qua

    AI research layers

    Interpretive context generated from the platform’s current data sources.

    No results

    AI research layers have not been published yet.

    Featured By